Manning Paul B 13D and 13G filings for Acumen Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:24 pm Sale |
2022-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS |
Manning Paul B | 3,205,128 7.800% |
-805,550 (-20.09%) |
Filing |
| 2022-02-14 7:27 pm Purchase |
2021-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS |
Manning Paul B | 4,010,678 9.900% |
4,010,678 (New Position) |
Filing |